Summary: This is a 5-year clinical research study to assess the long-term safety and effectiveness of an investigational (not approved by the FDA) drug for women who have gone through menopause or had their ovaries removed and have since experienced a decline in sexual desire, a condition called Hypoactive Sexual Desire Disorder (HSDD).
Participation qualifications:Benefits:
Study participants may receive study-related medical examinations, laboratory testing, and study medication or a placebo (an inactive substance).
Compensation up to $450.00 for time and travel is also available.
Participants cannot be enrolled in the clinical study until they have signed an informed consent form, completed screening, and have been fully evaluated at the study site.